European science conversations
by the community, for the community
Many of our daily products are made from pollutant materials, which have proven to be extremely difficult to recycle. Recently, there have been a number of high profile campaigns to raise awareness about the global plastic waste crisis. Specifically to raise awareness of single-use plastics (microbeads, packaging, bags, disposable products etc.), which make up approximately 40% of the now more than 448 million tons of plastic produced every year. In an effort to do their bit to help, some biotechnological companies within the healthcare sector have focused their efforts on the search for alternative materials to fabricate diagnostics products. Paper has emerged as a possibility, but is it actually a real option for the market? Read more [...]
Abstraction
Cancer treatment has evolved and improved over time. Within the past few years, many new options have become available for patients that were just a dream no more than a decade ago. Some of the new methods on the forefront of cancer treatment Read more [...]
What if patients and clinical experts could spark and define the direction of multidisciplinary science projects without knowing the scientific literature? The Ludwig Boltzmann Gesellschaft (LBG) — a Austrian research organisation located in Vienna — is currently experimenting with Open Innovation in Science to systematically steer missions for their future research groups. Open Innovation in Science has been a vital part of innovative R&D units in large companies, however the science side of things are just starting to develop. LBG is currently at the forefront of this development. Read more [...]
The Internet of Things has been a big buzz word in technology for a couple years now. The Internet of Things refers to how everyday devices are becoming connected or digitised with technology. Who would have thought that pills could be digitised and that prescribed medicines could become part of The Internet of Things? It happened this past November when the FDA (Food and Drug Administration) approved the first pill with a digital sensor. What does this mean for medicine? It means that the prescribing doctor can be notified when a patient takes their medication; or maybe even more importantly, if they didn’t take their medication as prescribed. Read more [...]
EuroScientist journal 
